Intrinsic Value of S&P & Nasdaq Contact Us

Simulations Plus, Inc. SLP NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
$37.46
+180.2%
Analyst Price Target
$56.00
+318.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Simulations Plus, Inc. (SLP) has a negative trailing P/E of -3.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 14.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -25.34%, forward earnings yield 7.17%. PEG 1.07.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+318.8%).
  • Forward P/E 14.0 — analysts expect a return to profitability with estimated EPS of $0.96 for FY2026.
  • PEG Ratio 1.07 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -25.34% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 7.17% as earnings recover.
  • Analyst consensus target $56.00 (+318.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
62/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SLP

Valuation Multiples
P/E (TTM)-3.9
Forward P/E14.0
PEG Ratio1.07
Forward PEG1.07
P/B Ratio1.99
P/S Ratio3.22
EV/EBITDA15.3
Per Share Data
EPS (TTM)$-3.19
Forward EPS (Est.)$0.96
Book Value / Share$6.31
Revenue / Share$3.91
FCF / Share$1.14
Yields & Fair Value
Earnings Yield-25.34%
Forward Earnings Yield7.17%
Dividend Yield0.00%
SharesGrow IV$37.46 (+180.2%)
Analyst Target$56.00 (+318.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 30.3 1.16 6.61 7.52 2.27%
2017 43.2 2.51 9.69 10.36 1.38%
2018 40.4 0.76 11.32 12.18 1.15%
2019 73.6 -12.76 16.76 18.59 0.66%
2020 113.8 18.58 6.80 25.53 0.40%
2021 90.8 -15.73 5.36 19.11 0.54%
2022 97.2 3.66 6.80 22.50 0.40%
2023 89.7 -4.63 5.25 14.99 0.54%
2024 72.8 0.00 3.97 10.35 0.66%
2025 -4.4 0.01 2.28 3.60 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.29 $19.97M $4.95M 24.8%
2017 $0.33 $24.14M $5.79M 24%
2018 $0.50 $29.67M $8.93M 30.1%
2019 $0.48 $33.97M $8.58M 25.3%
2020 $0.50 $41.59M $9.33M 22.4%
2021 $0.47 $46.47M $9.78M 21.1%
2022 $0.60 $53.91M $12.48M 23.2%
2023 $0.49 $59.58M $9.96M 16.7%
2024 $0.49 $70.01M $9.95M 14.2%
2025 $-3.22 $79.18M $-64.72M -81.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.04 $0.98 – $1.09 $80.42M $79.92M – $80.92M 4
2027 $1.08 $1.00 – $1.16 $85.31M $83.72M – $86.11M 4
2028 $1.10 $1.08 – $1.11 $93.3M $91.56M – $95.04M 1
2029 $1.28 $1.25 – $1.30 $103.4M $101.8M – $104.36M 1
2030 $1.56 $1.53 – $1.58 $117.1M $115.29M – $118.18M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message